Genetic analysis of Factor XII and bradykinin catabolic enzymes in a family with estrogen-dependent inherited angioedema

Journal of Allergy and Clinical Immunology

Volumn 123, Issue 4, 2009, Pages 906-910

  Duan, Qing Ling ^a,b   Binkley, Karen ^c   Rouleau, Guy A ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

aminopeptidase P; angiotensin I converting enzyme; bradykinin; coagulation Factor XII; Estrogen dependent inherited angioedema

Indexed keywords

AMINOPEPTIDASE P; BLOOD CLOTTING FACTOR 12; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE; ESTROGEN; LYSINE; THREONINE;

ALLELE; AMINO ACID SUBSTITUTION; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL ARTICLE; DNA POLYMORPHISM; ENZYME ACTIVITY; FEMALE; GENE DELETION; GENE INSERTION; GENE LOCUS; GENETIC ANALYSIS; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HUMAN; ITALY; MISSENSE MUTATION; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ADOLESCENT; ALLELES; AMINOPEPTIDASES; ANGIOEDEMA, HEREDITARY; BRADYKININ; ESTROGENS; FACTOR XII; GENOTYPE; HUMANS; MALE; MUTATION; PEPTIDYL-DIPEPTIDASE A;

EID: 63649128831     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2008.12.010     Document Type: Article

References (31)

1. Cyr M., Eastlund T., Blais Jr. C., Rouleau J.L., and Adam A. Bradykinin metabolism and hypotensive transfusion reactions. Transfusion 41 (2001) 136-150
2. Davis III A.E. The pathogenesis of hereditary angioedema. Transfus Apheresis Sci 29 (2003) 195-203
3. Agostoni A., Aygoren-Pursun E., Binkley K.E., Blanch A., Bork K., Bouillet L., et al. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 114 suppl (2004) S51-S131
4. Davis III A.E. C1 inhibitor and hereditary angioneurotic edema. Ann Rev Immunol 6 (1988) 595-628
5. Champion R.H., Roberts S.O., Carpenter R.G., and Roger J.H. Urticaria and angio-oedema. A review of 554 patients. Br J Dermatol 81 (1969) 588-597
6. Cicardi M., Bergamaschini L., Zingale L.C., Gioffre D., and Agostoni A. Idiopathic nonhistaminergic angioedema. Am J Med 106 (1999) 650-654
7. Vleeming W., van Amsterdam J.G., Stricker B.H., and de Wildt D.J. ACE inhibitor-induced angioedema. Incidence, prevention and management. Drug Saf 18 (1998) 171-188
8. Rafii M.S., Koenig M., and Ziai W.C. Orolingual angioedema associated with ACE inhibitor use after rtPA treatment of acute stroke. Neurology 65 (2005) 1906
9. Bork K., Barnstedt S.E., Koch P., and Traupe H. Hereditary angioedema with normal C1-inhibitor activity in women. Lancet 356 (2000) 213-217
10. Binkley K.E., and Davis III A. Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema. J Allergy Clin Immunol 106 (2000) 546-550
11. Dewald G., and Bork K. Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. Biochem Biophys Res Commun 343 (2006) 1286-1289
12. Cichon S., Martin L., Hennies H.C., Muller F., Van Driessche K., Karpushova A., et al. Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III. Am J Hum Genet 79 (2006) 1098-1104
13. Klein-Hitpass L., Tsai S.Y., Greene G.L., Clark J.H., Tsai M.J., and O'Malley B.W. Specific binding of estrogen receptor to the estrogen response element. Mol Cell Biol 9 (1989) 43-49
14. Farsetti A., Misiti S., Citarella F., Felici A., Andreoli M., Fantoni A., et al. Molecular basis of estrogen regulation of Hageman factor XII gene expression. Endocrinology 136 (1995) 5076-5083
15. Proud D., and Kaplan A.P. Kinin formation: mechanisms and role in inflammatory disorders. Annu Rev Immunol 6 (1988) 49-83
16. Nussberger J., Cugno M., and Cicardi M. Bradykinin-mediated angioedema. N Engl J Med 347 (2002) 621-622
17. Bhoola K.D., Figueroa C.D., and Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev 44 (1992) 1-80
18. Blais Jr. C., Rouleau J.L., Brown N.J., Lepage Y., Spence D., Munoz C., et al. Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema. Immunopharmacology 43 (1999) 293-302
19. Blais Jr. C., Marc-Aurele J., Simmons W.H., Loute G., Thibault P., Skidgel R.A., et al. Des-Arg9-bradykinin metabolism in patients who presented hypersensitivity reactions during hemodialysis: role of serum ACE and aminopeptidase P. Peptides 20 (1999) 421-430
20. Duan Q.L., Nikpoor B., Dube M.P., Molinaro G., Meijer I.A., Dion P., et al. A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors. Am J Hum Genet 77 (2005) 617-626
21. Molinaro G., Duan Q.L., Chagnon M., Moreau M.E., Simon P., Clavel P., et al. Kinin-dependent hypersensitivity reactions in hemodialysis: metabolic and genetic factors. Kidney Int 70 (2006) 1823-1831
22. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., and Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86 (1990) 1343-1346
23. Suehiro T., Morita T., Inoue M., Kumon Y., Ikeda Y., and Hashimoto K. Increased amount of the angiotensin-converting enzyme (ACE) mRNA originating from the ACE allele with deletion. Hum Genet 115 (2004) 91-96
24. Murphey L.J., Hachey D.L., Oates J.A., Morrow J.D., and Brown N.J. Metabolism of bradykinin in vivo in humans: identification of BK1-5 as a stable plasma peptide metabolite. J Pharmacol Exp Ther 294 (2000) 263-269
25. Scheer W.D., Boudreau D.A., Hixson J.E., McGill H.C., Newman III W.P., Tracy R.E., et al. ACE insert/delete polymorphism and atherosclerosis. Atherosclerosis 178 (2005) 241-247
26. Stevenson J.C., Oladipo A., Manassiev N., Whitehead M.I., Guilford S., and Proudler A.J. Randomized trial of effect of transdermal continuous combined hormone replacement therapy on cardiovascular risk markers. B J Haematol 124 (2004) 802-808
27. Sumino H., Ichikawa S., Kanda T., Sakamaki T., Nakamura T., Sato K., et al. Hormone replacement therapy in postmenopausal women with essential hypertension increases circulating plasma levels of bradykinin. Am J Hypertens 12 (1999) 1044-1047
28. Nogawa N., Sumino H., Ichikawa S., Kumakura H., Takayama Y., Nakamura T., et al. Effect of long-term hormone replacement therapy on angiotensin-converting enzyme activity and bradykinin in postmenopausal women with essential hypertension and normotensive postmenopausal women. Menopause 8 (2001) 210-215
29. Sumino H., Ichikawa S., Ohyama Y., Nakamura T., Kanda T., Sakamoto H., et al. Effects of hormone replacement therapy on serum angiotensin-converting enzyme activity and plasma bradykinin in postmenopausal women according to angiotensin-converting enzyme-genotype. Hypertens Res 26 (2003) 53-58
30. Drouet C., Desormeaux A., Robillard J., Ponard D., Bouillet L., Martin L., et al. Metallopeptidase activities in hereditary angioedema: effect of androgen prophylaxis on plasma aminopeptidase P. J Allergy Clin Immunol 121 (2008) 429-433
31. Binkley K.E., and Davis III A.E. Estrogen-dependent inherited angioedema. Transfus Apheresis Sci 29 (2003) 215-219